Smoking Cessation Pipeline Highlights - 2018

  • ID: 4516409
  • Report
  • Fore Pharma
20 % OFF
until Dec 31st 2018
1 of 3
The latest report Smoking Cessation Pipeline Highlights - 2018, provides most up-to-date information on key pipeline products in the global Smoking Cessation market. It covers emerging therapies for Smoking Cessation in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:
The report provides Smoking Cessation pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:
The report provides Smoking Cessation pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:
The report provides Smoking Cessation pipeline products by the company.

Short-term Launch Highlights:
Find out which Smoking Cessation pipeline products will be launched in the US and Ex-US till 2020.

SUMMARY:
  • Smoking Cessation phase 3 clinical trial pipeline products
  • Smoking Cessation phase 2 clinical trial pipeline products
  • Smoking Cessation phase 1 clinical trial pipeline products
  • Smoking Cessation preclinical research pipeline products
  • Smoking Cessation discovery stage pipeline products
  • Smoking Cessation pipeline products short-term launch highlights
Note: Product cover images may vary from those shown
2 of 3
1. Smoking Cessation Pipeline by Stages
2. Smoking Cessation Pipeline by Drug Class
3. Smoking Cessation Pipeline by Company
4. Smoking Cessation Phase 3 Clinical Trial Insights
5. Smoking Cessation Phase 2 Clinical Trial Insights
6. Smoking Cessation Phase 1 Clinical Trial Insights
7. Smoking Cessation Preclinical Research Insights
8. Smoking Cessation Discovery Stage Insights
9. Appendix
10. Research Methodology

List of Tables
Table 1: Smoking Cessation Phase 3 Clinical Trials, 2018
Table 2: Smoking Cessation Phase 2 Clinical Trials, 2018
Table 3: Smoking Cessation Phase 1 Clinical Trials, 2018
Table 4: Smoking Cessation Preclinical Research, 2018
Table 5: Smoking Cessation Discovery Stage, 2018

List of Figures
Figures 1: Smoking Cessation Pipeline Molecules by Clinical Trials Stage, 2018
Figure 2: Smoking Cessation Pipeline Molecules by Drug Class, 2018
Figure 3: Smoking Cessation Pipeline Molecules by Company, 2018
Figure 4: Smoking Cessation Phase 3 Clinical Trial Highlights, 2018
Figure 5: Smoking Cessation Phase 2 Clinical Trial Highlights, 2018
Figure 6: Smoking Cessation Phase 1 Clinical Trial Highlights, 2018
Figure 7: Smoking Cessation Preclinical Research Highlights, 2018
Figure 8: Smoking Cessation Discovery Stage Highlights, 2018
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll